|Date||October 21 - 23, 2015|
|Place||Gifu Grand Hotel
Address: 648 Nagara, Gifu 502-8567, Japan
WEB Site: http://www.gifugrandhotel.co.jp/en/
|Host||The Japanese Society for Retinoid Research|
|President||Hisataka MORIWAKI (President, Gifu University)|
|Society Chairman||Hisataka MORIWAKI (President, Gifu University)|
|Theme||Cross-cutting and International Collaboration|
|Congress Fee||5,000 JPY|
|Registration||Abstract submission is already closed.
The conference also look forward to your registration without abstract submission. If you would like to participate in the conference, please pay the registration fee on site. Advanced registration is not needed.
|Opening Reception||6:00 PM on Oct. 20th in the room HANA at Gifu Grand Hotel|
|Secretariat||c/o K and U Co., Ltd.
Hongo Bldg 3F, 7-2-2, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
I am pleased to announce that the 3rd International Conference on Retinoids will be held on 21th-23rd October this year in Gifu, Japan. This is joint meeting with the 26th Congress of the Japanese Society for Retinoid Research. In the past, the international conferences were convened in Italy in 2013 chaired by Dr. Erika Cione, and in Chicago in 2014 chaired by Drs. Li-Na Wei and Ethan Dmitrovsky.
After the discovery of the nuclear receptors, retinoid research has made dramatic strides. The findings of basic research have contributed to translational studies and led to successful results in this research field. In order to accelerate retinoid research, it is essential to expand basic research, including drug development, and construct the framework for cross-sectoral clinical research. In addition, international collaboration and cooperation are obviously needed.
In this meeting, experts from Asia, Europe, and North America will give us cutting-edge knowledge about basic, translation, and clinical practice in the research of retinoids. I hope all participants can find this international conference a truly stimulating and memorable event.
I look forward to your participation and hope everyone will like the beautiful and traditional city Gifu located in the center of Japan.
|Atsushi Miyawaki, M.D., Ph.D. (RIKEN Inst.)|
|Cécile Rochette-Egly, Ph.D. (IGBMC)|
|Earl H. Harrison, Ph.D. (Ohio State Univ.)|
|Erika Cione, Ph.D. (Univ. of Calabria)|
|Ethan Dmitrovsky, M.D. (MD Anderson Cancer Ctr.)|
|Hinrich Gronemeyer, Ph.D. (IGBMC)|
|Jonathan Corcoran, Ph.D. (King's College London)|
|Kohichi Kawahara, Ph.D. (Nigata Univ. of Pharmacy)|
|Li-Na Wei, Ph.D. (Univ. of Minnesota)|
|Lucia Altucci, M.D., Ph.D. (Second Univ. of Naples)|
|Makoto Iwata, Ph.D. (Tokushima Bunri Univ.)|
|Samuel Waxman, M.D. (Mount Sinai Medical Ctr.)|
|Ulrich Hammerling, Ph.D. (Sloan-Kettering Inst.)|
|William S. Blaner, Ph.D. (Columbia Univ.)|
|Xiao-kun Zhang, Ph.D. (Sanford-Burnham Inst.)|
Papers are currently being invited on the following topics:
- Nuclear receptors
The deadline for abstract submission has been extended to June 3, 2015.
With the information on your abstract in hand, click one of the buttons below to access the UMIN abstract registration page.
The Secretariat recommends that you use encrypted transmission for better security. However, if your communication software cannot access the encrypted transmission option, you will have to use the ordinary transmission option.
After completing your abstract registration, click the button for your case below and use your Registration Number and Password to access the abstract registration confirmation and correction page. If your abstract does not appear on the page, it means that it was not properly registered. Try again from the registration page. If you see your abstract, it can be corrected or revised here.
We again recommend that that you use encrypted transmission for better security. After completion and confirmation of the registration, your abstract will be examined. You will receive a notification of acceptance or rejection.
|Ajinomoto Pharmaceuticals Co., Ltd.|
|Bristol-Myers Squibb Foundation Grants|
|First Department of Internal Medicine, Gifu University|
|Gifu Convention and Visitors Bureau|
|JSPS Core-to-Core Program, A.|
Advanced Research Networks, on Center of International Research Platform for Biomedical Science and Drug Discovery against Intractable Diseases
|Kowa Company Ltd.|
|Mochida Memorial Foundation for Medical and Pharmaceutical Research|
|Otsuka Pharmaceutical Co., Ltd.|
|Taiho Pharmaceutical Co., Ltd.|
|Teijin Pharma Limited.|
|The Vitamin Society of Japan|
|Wako Pure Chemical Industries Ltd.|